WASHINGTON, DC: This week, the American Academy of HIV Medicine has launched a new podcast, The Academy Exchange: HIV Today & Tomorrow. This podcast will explore the latest news and advances in HIV prevention, care, and treatment, as well as examine the societal and systemic...
WASHINGTON, DC: This week, the American Academy of HIV Medicine launched a new online resource, www.hivlaa.org, to expand the knowledge base for long-acting antiretroviral agents (LAAs) used for the treatment and prevention of HIV. LAAs are innovative new tools in the fight against HIV that come...
WASHINGTON, DC: The American Academy of HIV Medicine and the Institute for Technology in Health Care have awarded the 2022 Cesar Augusto Caceres Award for Technology in HIV Practice to Dr. Hillary Liss and Dr. Jennifer Jones-Vanderleest of Seattle, Washington. Drs. Liss and Jones-Vanderleest are...
Washington, DC: This week, members of the American Academy of HIV Medicine, the nation’s leading network of HIV care providers, met with Congressional representatives to highlight four critical policy interventions needed to achieve the goal of ending the HIV epidemic by 2030. Over fifty Academy members...
The American Academy of HIV Medicine applauds the Biden Administration for prioritizing health care funding in the recently released budget proposal. With a $127.3 billion investment in discretionary programs and $1.7 trillion in mandatory programs for the Department of Health and Human Services (HHS), the...
WASHINGTON, DC: The Academy of HIV Medicine today announced the appointment of Angela C. Riley, PharmD, as their new Manager of Education and Web Programs. A licensed pharmacist, Angela’s clinical background will be instrumental in creating the Academy’s educational content, which extends to all members...
Upcoming Legislative Briefing Also Highlights the Needs of Workforce Expansion Washington, DC: The American Academy of HIV Medicine recognizes the need for greater racial diversity in our healthcare system, including within the HIV workforce. Studies show that racial and ethnic concordance between patients and providers is...
Washington, DC: In response to the Food and Drug Administration's recent approval of Apretude (cabotegravir extended-release injectable suspension) for prevention of HIV and the robust pipeline of additional long-acting antiretroviral agents currently under development, the American Academy of HIV Medicine is pleased to announce it...
Washington, DC: The American Academy of HIV Medicine, the nation’s largest independent HIV care provider organization, today commended the Biden Administration for releasing an updated National HIV/AIDS Strategy (NHAS), which renews the goal of ending the epidemic by 2030. President Biden unveiled the new plan...
Washington, DC: The American Academy of HIV Medicine, the nation’s leading non-profit representing frontline HIV care providers, warns that recent threats to the savings generated by the Federal 340B Drug Pricing Program will compromise access to affordable care, treatment and prevention services for underserved people...